Back to Search
JAMES BUTERA, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1790797538IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD10310(RI)
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 1994
Research & Publications (20)
Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation.
PMID 19175320·J Med Chem·2009
7-preclinical
Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-diones.
PMID 15863304·Bioorg Med Chem Lett·2005
8-other
Synthesis and potassium channel opening activity of substituted 10H-benzo[4,5]furo[3,2-b]indole-and 5,10-dihydro-indeno[1,2-b]indole-1-carboxylic acids.
PMID 11514146·Bioorg Med Chem Lett·2001
7-preclinical
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
PMID 10737752·J Med Chem·2000
7-preclinical
Novel progesterone receptor modulators with gene selective and context-dependent partial agonism.
PMID 19013437·Biochem Pharmacol·2009
7-preclinical
Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
PMID 19040490·Transfusion·2009
5-case
Prodrugs of perzinfotel with improved oral bioavailability.
PMID 19146418·J Med Chem·2009
7-preclinical
Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists.
PMID 19168056·Eur J Pharmacol·2009
4-observational
The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
PMID 19252062·J Pharmacol Exp Ther·2009
7-preclinical
Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).
PMID 19364658·Bioorg Med Chem·2009
8-other
Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents.
PMID 19616941·Bioorg Med Chem Lett·2009
7-preclinical
Left sided inferior vena cava duplication and venous thromboembolism: case report and review of literature.
PMID 19055711·J Hematol Oncol·2008
5-case
Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.
PMID 16344331·J Pharmacol Exp Ther·2006
7-preclinical
Ligands targeting the excitatory amino acid transporters (EAATs).
PMID 17017964·Curr Top Med Chem·2006
6-review
Dicentric (17;20)(p11.2;q11.2): an uncommon cytogenetic abnormality in myeloid malignancies.
PMID 16965957·Cancer Genet Cytogenet·2006
5-case
Making EmOC a reality--CARE's experiences in areas of high maternal mortality in Africa.
PMID 16442536·Int J Gynaecol Obstet·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 593 EDDY ST
PROVIDENCE, RI 02903 - Phone
- (401) 444-5391
Quick Facts
- NPI
- 1790797538
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile